Related Experiment Video
Updated: Sep 29, 2025

07:26
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
Published on: November 20, 2018
6.6K
Cubic Iron Core-Shell Nanoparticles Functionalized to Obtain High-Performance MRI Contrast Agents
Maria Volokhova1,2, Anna Shugai1, Masahiko Tsujimoto3
1National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.
Materials (Basel, Switzerland)
|March 25, 2022
Summary
New iron nanoparticles with silica coating show high magnetic properties and excellent biocompatibility. These nanoparticles demonstrate superior potential as magnetic resonance imaging (MRI) contrast agents compared to iron oxide nanoparticles.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Iron-based nanoparticles are explored for various applications, including magnetic resonance imaging (MRI).
- Optimizing magnetic properties and ensuring biocompatibility are key challenges in nanoparticle development.
Purpose of the Study:
- To synthesize and characterize novel iron nanoparticles with a silica (SiO2) coating.
- To evaluate the magnetic properties and in vitro biocompatibility of these nanoparticles.
- To assess their potential as magnetic resonance imaging (MRI) contrast agents.
Main Methods:
- Synthesis of cubic iron core nanoparticles coated with SiO2.
- Measurement of saturation magnetization.
- In vitro toxicology studies.
- Comparison with iron oxide nanoparticles for MRI contrast enhancement.
Main Results:
- Synthesized nanoparticles exhibited saturation magnetization close to theoretical maximums for iron-based materials.
- In vitro studies confirmed high biocompatibility of the SiO2-coated iron nanoparticles.
- The nanoparticles demonstrated superior MRI contrast agent potential compared to conventional iron oxide nanoparticles.
Conclusions:
- SiO2-coated cubic iron nanoparticles offer exceptional magnetic properties and biocompatibility.
- These nanoparticles represent a promising advancement for MRI contrast agents.
- Further research is warranted to explore their full clinical potential.

